awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q45403481-5480BDB2-1799-4993-B56D-0205A14E48FF
Q45403481-5480BDB2-1799-4993-B56D-0205A14E48FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45403481-5480BDB2-1799-4993-B56D-0205A14E48FF
Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?
P2860
Q45403481-5480BDB2-1799-4993-B56D-0205A14E48FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45403481-5480BDB2-1799-4993-B56D-0205A14E48FF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
159588975bec04845c70b6c2c349146e7f295224
P2860
Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme.